Thrombolytic Therapy for Acute Myocardial Infarction
Trials of thrombolytic therapy have taught us that 1) lysis of hemostatic plugs, not fibrinogenolysis, is the major cause of bleeding complications; 2) as currently reported, patency rates 90 minutes after the onset of therapy are both meaningless and misleading as surrogate end-points for either my...
Guardat en:
| Publicat a: | Tex Heart Inst J |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Texas Heart Institute
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC324975/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15227491/ |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|